Stephanie Fohn

Craxel’s proprietary technology maintains an exquisite map of your data at a speed and cost that is simply unprecedented in the history of computing. This allows petabytes of data to be queried at incredible speeds and at a marginal cost that allows you to maximize the value of your data. Extreme query speed and cost performance are only possible if your data is organized to an unprecedented degree. Computer scientists have been trying to solve the problem of quickly and cost-effectively organizing information for decades. Craxel has solved for this.

PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. Our highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatment at the tumor site. This distinctive targeting capability uniquely positions us to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.

PeakSpan Capital is a growth equity firm based in New York City and Silicon Valley. Having partnered with over 57 scale-ups and with $2.5B+ in assets under management (AUM), PeakSpan’s mission is to be the partner of choice for growth-stage entrepreneurial teams building category-defining software for business buyers of all sizes. PeakSpan combines deep domain expertise across a select set of sectors with multiple homegrown, proprietary, and patented technology platforms that provide visibility into company and market performance, helping disruptive entrepreneurs drive resilient, risk-adjusted value creation. To learn more about PeakSpan Capital and its portfolio, please visit: www.peakspancapital.com.

Craxel’s proprietary technology maintains an exquisite map of your data at a speed and cost that is simply unprecedented in the history of computing. This allows petabytes of data to be queried at incredible speeds and at a marginal cost that allows you to maximize the value of your data. Extreme query speed and cost performance are only possible if your data is organized to an unprecedented degree. Computer scientists have been trying to solve the problem of quickly and cost-effectively organizing information for decades. Craxel has solved for this.

PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. Our highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatment at the tumor site. This distinctive targeting capability uniquely positions us to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.

PeakSpan Capital is a growth equity firm based in New York City and Silicon Valley. Having partnered with over 57 scale-ups and with $2.5B+ in assets under management (AUM), PeakSpan’s mission is to be the partner of choice for growth-stage entrepreneurial teams building category-defining software for business buyers of all sizes. PeakSpan combines deep domain expertise across a select set of sectors with multiple homegrown, proprietary, and patented technology platforms that provide visibility into company and market performance, helping disruptive entrepreneurs drive resilient, risk-adjusted value creation. To learn more about PeakSpan Capital and its portfolio, please visit: www.peakspancapital.com.